 Global pharmaceutical company, AstraZeneca plans to grow its footprint in Sub-Saharan Africa by improving access to innovative medicines. The firm is currently implementing ‘Healthy Heart Africa’ in Kenya and Ethiopia to assist people living with high blood pressure. Joining CNBC Africa to discuss the company’s future investment in the region is Country President for Sub-Saharan and French Speaking Africa, Jeroen Commissaris. 